BioNTech SE - ADR vs Tapestry, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Tapestry, Inc. trades at $161 (market cap $32.44B). The key difference: Tapestry, Inc. is the larger of the two by market cap, and Tapestry, Inc. pays a 1% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | TPR | |
|---|---|---|
Market Cap | $23.31B | $32.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $164.78 |
52-Week Low | $83.89 | $95.69 |
Enterprise Value | $6.60B | $35.29B |
Dividend Yield | — | 1% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →